⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2024

Figure S6 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER⁺ Breast Cancer

Anran Chen Beom-Jun Kim Aparna Mitra Craig T. Vollert Jonathan T. Lei Diana Fandino Meenakshi Anurag Matthew V. Holt Xuxu Gou Jacob B. Pilcher Matthew P. Goetz Donald W. Northfelt Susan G. Hilsenbeck C. Gary Marshall Marc L. Hyer Robert Papp Shou-Yun Yin Carmine De Angelis Rachel Schiff Suzanne A.W. Fuqua X. Cynthia Charles E. Foulds Matthew J. Ellis

View at Publisher

Ask AI

Bookmark

Share

Abstract

Correlation of PKMYT1 protein levels with Hallmark scores in ER+ breast cancer PDXs

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efef64 https://doi.org/10.1158/1535-7163.27142228

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S4 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
2Figure S1 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
3Figure S2 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
4Table S3 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
5Figure S10 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024